Guided Therapeutics (GTHP) Receives Grant to Assist in Commercialization of Cervical Cancer Detection Technology

QualityStocks would like to highlight Guided Therapeutics, Inc. (OTCBB & OTCQB: GTHP). The company is developing a rapid and painless testing platform for the early detection of disease, based on its patented biophotonic technology that utilizes light to detect disease at the cellular level.

In the company’s news yesterday,

Guided Therapeutics announced that the National Cancer Institute recently awarded the company $517,000 to fund the final year of a $2.5 million, three-year grant.

The grant provides the company with the necessary resources to help commercialize and bring to market the LuViva(TM) Advanced Cervical Scan and Cervical Guide single-patient-use disposable.

LuViva is a non-invasive device that provides immediate detection of cervical disease by scanning the cervix with light, instantly detecting and identifying cancer and pre-cancer. The technology is a stark contrast to Pap or HPV tests, in that it does not require laboratory analysis or a tissue sample.

LuViva is currently under pre-market approval (PMA) review by the U.S. Food and Drug Administration.

Since 2011, Guided Therapeutics has been awarded more than $6 million in six consecutive grants from the NCI to support the company’s development of new, pain-free test for detecting cervical disease.

“We view the continuation of the grant as further third-party validation of our technology and it provides additional non-dilutive resources to complete the regulatory process and begin manufacturing,” Mark L. Faupel, Ph.D., president and CEO of Guided Therapeutics stated in the press release.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.